AnalysisNews

CGEM today

$11.35+$0.12 (+1.07%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourLeaning Bullish

1 hourLeaning Bearish

15 minSymmetric Triangle

5 minLeaning Bullish

Daily trend turns up above $16.18

Key levels

Resistance$14.81

Resistance$12.77

Support$10.69

Support$8.23

Latest news & SEC filings

AnalystNov 11, 2026Wedbush keeps Outperform on Cullinan Therapeutics, lifts target to $44

EarningsNov 10, 2026Cullinan Therapeutics Posts Q3 2026 Results

EarningsNov 10, 2026Cullinan Therapeutics posts smaller Q3 loss than expected

SEC FilingNov 10, 2026Cullinan Therapeutics, Inc. filed a report on a major company event (Form 8-K)

All CGEM news →

About Cullinan Therapeutics

Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its pipeline includes CLN-978 and velinotamig, T cell engagers aimed at autoimmune conditions such as lupus, rheumatoid arthritis, and Sjogren's disease, plus CLN-049 for acute myeloid leukemia and myelodysplastic syndrome. The company also collaborates with Taiho Pharmaceutical on zipalertinib, a lung cancer drug candidate. It operates in the United States, Europe, and Australia.

Based on the company's 10-K filed Mar 10, 2026.

Nasdaq · Healthcare

Cullinan Therapeutics, Inc. (CGEM)

$11.35+0.12 (+1.07%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
11.8912.9814.0715.1611.35Oct 9Oct 19Oct 27Nov 4
High11.68
Low11.15
Open11.34
Volume950K
Avg Vol840K
VWAP11.33
30d High16.25
30d Low10.80
30d Chg-21.89%
See full chart with real-time data

What Is the Price Target for CGEM?

SEPT Low Target

$35.00

SEPT Mid Target

$40.50

SEPT High Target

$44.00

Analyst Consensus

$40.50

Current: $11.35Upside: +256.8%Confidence: 65%Method: Analyst Consensus

Is CGEM a Buy or Sell Right Now?

58
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 10▼ DownEarnings3 articles
Cullinan Therapeutics reported Q3 2026 results, posting a quarterly loss of $0.74 per share, which was narrower than the $0.84 loss analysts had projected. The company also filed a Form 8-K disclosing a major company event. Despite the better-than-expected earnings, the stock fell 4.10% to close at $11.23, trading between a low of $10.95 and a high of $12.04 on volume of 788,700 shares. The positive earnings surprise did not translate into a price gain, suggesting the market may have focused on other aspects of the release or the 8-K filing.

Thesis

    AI-Powered Trading Signals

    Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CGEM.

    Start Free Trial →

    Is CGEM Overvalued or Undervalued?

    Valuation Verdict

    UNDERVALUED

    Methods Used

    Analyst Consensus

    Fair Value

    $40.50

    12

    Moat Score

    NONE

    1/9

    Piotroski Score

    N/A

    Altman Z-Score

    What Is Smart Money Doing with CGEM?

    Insider Signal

    SELLING

    0 buys / 16 sells (90d)

    Congress Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Institutional

    N/A

    Short Squeeze Risk

    HIGH

    Signal: HIGH_SHORT_INTEREST

    Recent Insider Activity

    NameTitleTypeSharesValueDate
    Michaelson JenniferofficerBuy3,805$16KNov 5, 2026
    Michaelson JenniferofficerSale4,000$49KNov 5, 2026

    Track Smart Money Across 4,000+ Stocks

    Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

    See All Smart Money Signals →

    CGEM Growth Story

    Revenue YoY

    N/A%

    3yr Revenue CAGR

    N/A%

    EPS Growth YoY

    N/A

    FCF Growth YoY

    -21.0%

    Revenue Trend

    UNKNOWN

    Dark Pool Trades for CGEM

    PREVIEW

    SEPT Investing tracks real-time dark pool institutional trades for CGEM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

    TimePriceSizeValueSide
    23:13:58$11.682,500$$29KBUY
    21:00:22$11.352,023$$23KSELL
    21:00:20$11.352,582$$29KSELL
    21:00:19$11.358,391$$95KSELL
    20:42:15$11.381,047$$12KBUY

    5 dark pool trades shown · $$189K preview volume

    Real-time institutional flow, block trades, and net positioning

    See all dark pool activity

    Options Flow for CGEM

    PREVIEW

    SEPT Investing provides real-time options flow tracking for CGEM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

    TypeStrikeExpiryDTEPremiumSizeTrade
    CALL$17Dec 17401$$3151SWEEP
    PUT$10Dec 17401$$3301SWEEP
    CALL$11Dec 1837$$4551SWEEP
    CALL$11Jan 1565$$4901SWEEP
    CALL$11Dec 1837$$2371SWEEP

    5 options trades shown · 80% calls

    Unusual activity, GEX levels, max pain, and dealer positioning

    See full options flow

    Full AI Research Report

    SEPT's Trading AI has generated a free, downloadable PDF research report for Cullinan Therapeutics, Inc. (CGEM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

    Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

    Sign Up Free — Download AI Report PDF →

    AI-Powered Trading Signals.

    Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

    Try SEPT Free for 7 Days →

    Compare SEPT with other platforms

    SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
    What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

    About SEPT Investing

    SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

    Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

    CGEM — frequently asked questions

    What is CGEM stock price today?

    Cullinan Therapeutics, Inc. (CGEM) is at $11.35, up 1.07% (+$0.12) at the Nov 11, 2026 close.

    Why is CGEM stock up today?

    Nov 10, 2026: Cullinan Therapeutics reported Q3 2026 results, posting a quarterly loss of $0.74 per share, which was narrower than the $0.84 loss analysts had projected. The company also filed a Form 8-K disclosing a major company event.

    What is the CGEM price target?

    The average analyst price target for CGEM is $40.50, ranging from $35 to $44, based on 4 analysts. Latest: Wedbush maintains on Nov 11, 2026.

    What do analysts rate CGEM?

    Analyst ratings for CGEM: 0 Buy, 15 Hold, 0 Sell — consensus Hold.

    Did CGEM beat earnings?

    CGEM last reported on Nov 10, 2026: EPS -$0.74 vs -$0.84 expected — a beat of 11.9%.

    Does CGEM pay a dividend?

    CGEM does not currently pay a dividend.

    What are CGEM support and resistance levels?

    Support: $10.69, $8.23. Resistance: $12.77, $14.81, $16.18.

    What are insiders doing with CGEM?

    Insider activity: SELLING, 0 buys and 16 sells in the last 90 days.

    What is the latest news on CGEM?

    Nov 11, 2026: Wedbush keeps Outperform on Cullinan Therapeutics, lifts target to $44 · Nov 10, 2026: Cullinan Therapeutics Posts Q3 2026 Results · Nov 10, 2026: Cullinan Therapeutics posts smaller Q3 loss than expected